Clinical Trials Browser

Phase 2 × NIH × Androgen Antagonists × Clear all

NCT00003517 2013-07-10

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms